期刊文献+

重组人骨保护素与重组核因子κb活化因子受体蛋白对破骨前体细胞分化的影响 被引量:13

Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors
下载PDF
导出
摘要 目的:对比重组人骨保护素(rhOPG-Fc)与重组核因子κb活化因子受体蛋白(rhRANK)对破骨前体细胞分化的影响。方法:采用成骨细胞与破骨前体细胞RAW264.7混合培养,在地塞米松、1,25(OH)2VitD3诱导下生成破骨细胞的方法。研究分3组:rhRANK组:10-5g/L;rhOPG-Fc组:10-5g/L;空白对照组。作用9d后观察破骨细胞数目和形态,抗酒石酸酸性磷酸酶(TRAP)染色阳性细胞个数,骨磨片吸收陷窝计数。结果:在空白对照组,小鼠成骨细胞与破骨前体细胞RAW264.7混合培养6d后,开始出现多核细胞,9d时可见大量成熟多核细胞,经TRAP染色证实为成熟破骨细胞,而rhRANK组及rhOPG-Fc组TRAP染色阳性多核细胞数较对照组均减少,特别是rhRANK组减少更明显。骨片吸收陷窝计数显示rhRANK组及rhOPG-Fc组较对照组也明显减少,而相对来说,rhRANK组较rhOPG-Fc组更少。结论:rhOPG-Fc与rhRANK均可以有效抑制破骨前体细胞分化成为成熟破骨细胞,且rhRANK较rhOPG-Fc抑制效果更明显。 Objective :To compare the effect of recombinant OPG-Fc and recombinant RANK protein on the differentiation of osteoclast precursors. Methods: Mouse osteoblasts cell lines were incubated with osteoclast precursors cell lines RAW 264.7 for 9 days with 10-5 g/L rhRANK or rhOPG-Fc or PBS added to the cocuhure system. TRAP stain positive cells counting and cortical bone pit formation counting were performed in the 9th day. Results: Muhinuleated TRAP stain positive cells were observed in the cocluture systems after 6 days incubation, and plenty of mature osteoclasts could be observed in the 9th day. With the addition of 10-s g/L rhOPG-Fc or rhRANK,multinucleated giant cells and cortical bone pit formation couting decreased significantly compared with the control group, and the rhRANK group decreased more significantly than the rhOPG-Fc group. Conclusions:Both rhOPG-Fc and rhRANK can inhabit the differentiation of osteoclast precursors and prevent them forming mature osteoclasts ,moreover,the rhRANK shows the significant inhabition effect than the rbOPG-Fc.
出处 《中国骨伤》 CAS 2013年第4期324-327,共4页 China Journal of Orthopaedics and Traumatology
基金 国家自然科学基金(编号:81000796 30973068)~~
关键词 骨保护素 核因子κb活化因子受体蛋白 破骨前体细胞 细胞分化 Osteoprotegerin (OPG) Receptor activator of nuclear factor Kb protein (RANK) Osteoclast precursor Cell differantiation
  • 相关文献

参考文献7

二级参考文献75

  • 1戴芳,王宝利,梁晖,戴晨琳,邱明才.小鼠破骨细胞样细胞的诱导培养及重组ODF胞外片段对其影响[J].天津医药,2004,32(10):630-632. 被引量:1
  • 2杨慧敏,王玎玎,王雪萍.破骨细胞的起源[J].生物学通报,1995,30(9):7-9. 被引量:1
  • 3Blair HC,Athanasou NA.Recent advances in osteoclast biology andpathological bone resorption[J].Histol Histopathol,2004,19(1):189-199.
  • 4Komano Y,Nanki T,Hayashida K,et al.Identification of a humanperipheral blood monocyte subset that differentiates into osteoclasts[J].Arthritis Res Ther,2006,8(5):152.
  • 5Intan Zarina ZA,Shahrul Hisham ZA,Rohaya MAW,et al.Osteo-clast and osteoblast development of mus musculus haemopoieticmononucleated cells[J].J Biolog Sci,2008,8(3):506.
  • 6Henriksen K,Bollerslev J,Everts V,et al.Osteoclast activity andsubtypes as a function of physiology and pathologyi-mplications forfuture treatments of osteoporosis[J].Endocr Rev,2011,32(1):31-63.
  • 7Li J,Sarosi I,Yan XQ,et al.RANK is the intrinsic hematopoieticcell surface receptor that controls osteoclastogenesis and regulationof bone mass and calcium metabolism[J].Proc Natl Acad Sci US-A,2000,97(4):1566-1571.
  • 8Woo JT,Kato M,Takami M,et al.Receptor activator of NF-kap-paB ligand induces the fusion of mononuclear preosteoclasts intomultinucleated osteoclasts[J].Cytotechnology,2000,33(1-3):203-211.
  • 9Tsurukai T,Udagawa N,Matsuzaki K,et al.Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in os-teoclastogenesis[J].J Bone Miner Metab,2000,18(4):177-184.
  • 10Domon T,Wakita M.Electron microscopic and histochemicalstudies of the mononuclear osteoclast of the mouse[J].Am J Anat,1991,192(1):35-44.

共引文献35

同被引文献151

  • 1赵福涛,韩星海,管剑龙.髋关节X射线放射治疗对强直性脊柱炎髋关节病变改善效应的3年随访[J].中国临床康复,2005,9(34):88-91. 被引量:3
  • 2夏明,丁寿玲,张寒冰,刘昉,尹海英,许安廷.破骨细胞分化因子及其相关因子在中耳胆脂瘤组织中的表达[J].临床耳鼻咽喉头颈外科杂志,2007,21(7):315-317. 被引量:6
  • 3张川,李孝鹏,符诗聪,邹志强,朱雅萍,张风华.雄激素对体外成骨细胞OPG及其配体基因表达的影响[J].中国骨质疏松杂志,2007,13(2):77-81. 被引量:8
  • 4Lacey D,Timms E,Tan H,et al. Osteoprotegerin ligand is a cy- tokine that regulates osteoclast differentiation and activation [J]. Cell, 1998,93 (2) : 165-176.
  • 5Simonet W, Lacey D, Dunstan C, et al. Osteoprotegerin : a novel se- creted protein involved in the regulation of bone density[J]. Cell, 1997,89(2) :309-319.
  • 6Hofbauer LC ,Schopper M. Clinical implications of the osteoprote- gering/RANKL/RANK system for bone and vascular diseases [J]. JAMA, 2004,292 (4) :490-495.
  • 7Chambers TJ,Thomson BM, Fuller K. Effect of substrate composi- tion on bone resorption by rabbit osteoclasts[J]. J Cell Sci, 1984, 70:61-71.
  • 8Jurdic P,Saltel F, Chabadel A,et al. Podosome and sealing zone: specificity of the osteoclast model [ J ]. Eur J Cell Biol, 2006,85 ( 3- 4) : 195-202.
  • 9Destaing O, Saltel F, Geminard JC, et al. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein[J]. Mol Biol Cell,2003,14(2): 407-416.
  • 10Saltel F, Destaing O, Bard F, et al. Apatitemediated actin dynamics in resorbing osteoclasts [ J ]. Mol Biol Cel, 2004,15 ( 12 ) : 5231-5241.

引证文献13

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部